Compare · BLLN vs ELV
BLLN vs ELV
Side-by-side comparison of BillionToOne Inc. (BLLN) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLLN and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $90.24B, about 20.2x BLLN ($4.47B).
- Over the past year, BLLN is down 11.2% and ELV is up 7.1% - ELV leads by 18.3 points.
- ELV has been more active in the news (3 items in the past 4 weeks vs 1 for BLLN).
- ELV has more recent analyst coverage (23 ratings vs 8 for BLLN).
PerformanceBLLN-11.23%ELV+32.65%
2025-11-06+0.00%2026-06-08
- Company
- BillionToOne Inc.
- Elevance Health Inc.
- Price
- $97.40+0.33%
- $417.20+0.37%
- Market cap
- $4.47B
- $90.24B
- 1M return
- +4.84%
- +11.89%
- 1Y return
- -11.23%
- +7.07%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 1
- 3
- Recent ratings
- 8
- 23
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest BLLN
- BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference
- Large owner Neotribe Ventures I, L.P. disposed of 450,779 shares and acquired 14,828 shares (SEC Form 4)
- Director Kolluri Krishna Kittu disposed of 450,779 shares and acquired 31,028 shares (SEC Form 4)
- SEC Form 10-Q filed by BillionToOne Inc.
- BillionToOne Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance
- BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics
- SEC Form DEFA14A filed by BillionToOne Inc.
- SEC Form DEF 14A filed by BillionToOne Inc.
- BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
Latest ELV
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)
- Elevance Health upgraded by Deutsche Bank with a new price target
- Director Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)
- Director Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)
- Director Peru Ramiro G was granted 563 shares, increasing direct ownership by 6% to 9,908 units (SEC Form 4)
- Director Neri Antonio F was granted 563 shares, increasing direct ownership by 11% to 5,488 units (SEC Form 4)
- Director Jallal Bahija was granted 563 shares, increasing direct ownership by 12% to 5,351 units (SEC Form 4)
- Director Hay Lewis Iii was granted 563 shares, increasing direct ownership by 5% to 12,070 units (SEC Form 4)
- Director Dixon Robert L Jr was granted 563 shares, increasing direct ownership by 5% to 10,885 units (SEC Form 4)